Filing Details
- Accession Number:
- 0001396814-24-000088
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-07-03 18:52:22
- Reporting Period:
- 2024-06-28
- Accepted Time:
- 2024-07-03 18:52:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1396814 | Pacira Biosciences Inc. | PCRX | Pharmaceutical Preparations (2834) | 510619477 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1875723 | Jonathan Slonin | C/O Pacira Biosciences, Inc. 5401 West Kennedy Boulevard, Suite 890 Tampa FL 33609 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-06-28 | 437 | $24.32 | 99,307 | No | 5 | A | Direct | |
| Common Stock | Disposition | 2024-07-01 | 914 | $28.46 | 98,393 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2024-07-02 | 2,836 | $28.25 | 95,557 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | A | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents shares of common stock acquired under the issuer's employee stock purchase plan in June 2024.
- Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
Billionaire Hedge Funds
